SIERRA DELEON: Open Payments
NPI 1306266739 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 10 payments from 8 companies in 2025. Trend: 2023 $101 · 2024 $0 · 2025 $407
Food & beverage: $307Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $121 |
| Legend Biotech USA Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| PFIZER INC. | 1 | $33 |
| Caris MPI, Inc. | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Acera Surgical, Inc. | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: RYBREVANT, CARVYKTI, PADCEV, MI CANCER SEEK, MYRISK, Restrata Wound Matrix, Trodelvy.
Industry payments across CO — which companies pay providers there.
